Kirin Holdings Company and Blackmores Limited, one of Australia’s leading natural health companies and a member of the Kirin Group, have announced the upcoming launch of two new cognitive support supplements featuring Cognizin Citicoline from Kyowa Hakko Bio Co., Ltd, a Kirin Group company.

The new products will launch as Blackmores Cognition Ultra in Australia and Blackmores Ultra Brain Care in New Zealand, with a phased rollout beginning in late July 2026.
The products share the same formulation, with labelling adapted to meet the regulatory requirements of each market.
The launch marks the first Blackmores product developed to enhance cognitive performance and reflects the Kirin Group’s continued focus on advancing innovation in the health science domain.
Since Blackmores joined the Kirin Group in August 2023, the companies have been working together to address health needs across the Asia-Pacific region by combining Blackmores’ consumer insights, trusted brand presence and product development capabilities with Kyowa Hakko Bio’s expertise in scientifically supported ingredients.
Cognitive function plays an important role in quality of life, supporting memory, attention, focus and mental clarity throughout adulthood.
As awareness grows around age-related cognitive changes and the importance of proactive brain health, consumers are increasingly seeking solutions that support cognitive performance as part of a healthy lifestyle.
“Our purpose is to support people’s long-term health by combining the best of nature with science,” said Alastair Symington, Senior Executive Officer, Kirin Holdings; President, Kirin Health Science International; and CEO & Managing Director, Blackmores Limited.
“Leading research continues to highlight the importance of caring for brain health as we age."
"Blackmores Cognition Ultra and Blackmores Ultra Brain Care are designed to support brain performance, health and function as part of a healthy lifestyle. Together, they reflect our commitment to helping people live well for the long-term."